Uptake was terminated by rinsing the everted sacs briefly in ice-cold saline. The uptake into the tissue was evaluated by determining the radioactivity after solubilization of a half of each everted sac, using 1 ml Soluene-350 as a tissue solubilizer and 5 ml Scintisol EX-H as a scintillation fluid.
In experiments to test the effects of 2,4-dinitrophenol (DNP) and sodium azide (NaN 3 ), which are metabolic inhibitors, and p-chloromercuribenzene sulfonate (pCMBS), a thiol-modifying reagent, on glycerol uptake, these inhibitors were added to the preincubation solution as well as the test solution. To test the effects of other compounds, each compound was added only to the test solution so that they were present only during uptake. When the uptake under Na ϩ -free conditions was evaluated, the NaCl in the preincubation solution as well as the test solution was replaced by KCl, NH 4 Cl, choline Cl, or manntiol, and NaHCO 3 was replaced by KHCO 3 .
A series of experiments were also conducted to examine the effects of various compounds on the uptake of D-glucose and 5-fluorouracil for comparison with their effects on glycerol uptake. In these experiments, 3 H-labeled D-glucose and 5-fluorouracil were used with 14 C-labeled PEG 4000.
Data Treatment The uptake was estimated by subtracting the amount in the adherent fluid and the amount initially adsorbed to the everted sac, and was expressed in terms of 100 mg wet tissue weight (wtw). The adherent fluid volume was estimated by dividing the amount of PEG 4000 associated with the everted sac by its concentration in the medium. The uptake rate (J) was calculated by dividing the uptake by time during the initial uptake phase (1 min for the small intestine and 5 min for the colon), where uptake was proportional to time. The uptake clearance (CL up ) was calculated by dividing J by the concentration in the medium (C m ).
The expression of CL up for Michaelis-Menten type carrier-mediated transport with simultaneous passive transport is as follows: (1) where J max , K m and CL m,d are the maximum transport rate, the Michaelis constant and the membrane permeability clearance for passive transport, respectively. The kinetic parameters of J max , K m and CL m,d were estimated by fitting Eq. 1 to the experimental data of CL up versus C m profile using a nonlinear regression program, WinNonlin (Pharsight Co., Mountain View, CA, U.S.A.), and the reciprocal of variance as the weight.
The expression of CL up in the presence of a competitive inhibitor is as follows: (2) where C i and K i are the concentration of the inhibitor and the inhibition constant, respectively. With the values of J max , K m and CL m,d fixed at those determined in the absence of the inhibitor, K i was estimated by fitting Eq. 2 to the experimental CL up versus C m profile for a given C i .
Statistical Analysis Levels of statistical significance were assessed using Student's t-test or, when multiple comparisons were needed, analysis of variance (ANOVA) followed by Dunnett's test.
RESULTS

Time-Courses of Glycerol Uptake
The uptake of glycerol (2 mM) increased in proportion to time up to 1 min in the everted sacs of the small intestine, as shown in Fig. 1 . In the everted sacs of the colon, it was much slower and in proportion to time up to 5 min. Based on these results, the initial uptake of glycerol was evaluated at 1 and 5 min, respectively, after initiation of uptake for the small intestine and colon in subsequent experiments.
Glycerol Uptake by Na ؉ -Dependent Active Transport The clearance of glycerol uptake by the everted sacs of the small intestine decreased markedly when the concentration of glycerol was increased from 2 mM to 40 mM (Table 1) , suggesting the involvement of saturable transport. The kinetic analysis of the concentration-dependent profile of the uptake clearance (CL up ) revealed that, as shown in Fig. 2 , the saturable transport conformed to Michaelis-Menten type carrier-mediated transport with a J max of 11.5 nmol/min/ 100 mg/wtw and a K m of 0.77 mM, and was accompanied by unsaturable transport (passive transport) with a CL m,d of 
Fig. 2. Concentration-Dependent Glycerol Uptake in the Everted Sacs of the Rat Small Intestine
Data represent the meanϮS.E. (nϭ3). The uptake was evaluated at 37°C and 1 min in the absence of inhibitors (᭺), or in the presence of 5 mM chloramphenicol (᭹) or 10 mM voglibose (). Solid lines represent the computer-fitted profiles. The J max , K m and CL m,d are 11.5Ϯ1.9 nmol/min/100 mg wtw, 0.77Ϯ0.13 mM and 4.9Ϯ0.2 ml/min/100 mg wtw, respectively, as computer-fitted parameters with S.E. The K i values are 2.77Ϯ0.27 mM for chloramphenicol and 3.39Ϯ0.43 mM for voglibose. Shown in the inset are the Eadie-Hofstee plots of the carrier-mediated transport component, using the mean values of the transport rate, J c (nmol/min/100 mg wtw), and J c /C, where C is the concentration (mM). In the plots, data for 40 mM were excluded because the contribution of carrier-mediated transport was negligible. 4.9 ml/min/100 mg wtw. The J max /K m , which represents the coefficient of carrier-mediated transport at concentrations far below K m , was 14.9 ml/min/100 mg wtw, being about 3 times greater than CL m,d . Therefore, at such low concentrations, carrier-mediated transport is the major transport mechanism, accounting for about 75% of the total transport. At a trace glycerol concentration of 2 mM, where CL up is high with the contribution of carrier-mediated transport being predominant, glycerol uptake was significantly reduced when Na ϩ was removed by substitution of NaCl by KCl, NH 4 Cl, choline Cl and mannitol ( Table 1 ). As shown in Table 2 , it was also found that the CL up at 2 mM glycerol was reduced by DNP and NaN 3 , compounds which are metabolic inhibitors, to levels comparable with the CL up at 40 mM, which was comparable with the CL m,d and, hence, could be assumed to represent passive transport. It is presumed that metabolic inhibitors inhibit solute uptake via Na ϩ -dependent carriermediated mechanisms by raising the intracellular Na ϩ concentration and, thereby, reducing the inward Na ϩ concentration gradient, because they inhibit the production of ATP as the energy source and, thereby, hinder the active efflux of Na ϩ from the cell by Na ϩ /K ϩ -ATPase. These results suggest that the carrier-mediated glycerol transport is Na ϩ -dependent and secondary active. Since glycerol uptake was also inhibited by pCMBS, a thiol-modifying reagent, cysteine residues, which have a thiol group, seem to play an important role in the function of the carrier, as suggested for Na ϩ -dependent D-glucose transporter 1 (SGLT1) 8) and several other carriers. [9] [10] [11] [12] [13] At the higher concentration of 40 mM (Tables 1, 2) , glycerol uptake was not altered by NaCl substitution or DNP, consistent with the suggestion that the contribution of passive transport is predominant.
The uptake of glycerol by the everted sacs of the colon was also saturable and Na ϩ -dependent (Table 1) . Although it was about 10 times lower than that in the small intestine, it is likely that glycerol uptake in the colon is also in part governed by a Na ϩ -dependent carrier-mediated transport system. Inhibition of Glycerol Uptake by Alcohol-Related Compounds Finding inhibitors, which could include potential substrates, is helpful for clarifying the substrate specificity of a carrier-mediated transport system and for investigating the transport mechanism. We, therefore, examined the effect of various compounds, including alcohol-related compounds analogous to glycerol, on glycerol uptake using everted sacs of the small intestine at a trace glycerol concentration of 2 mM, where kinetic analysis had suggested that carrier-mediated transport was predominant.
Among the alcohol-related compounds (Fig. 3) , glycerol-3-phosphate, voglibose and chloramphenicol were found to significantly inhibit glycerol uptake, while dimercaprol, mephenesin and methocarbamol did not. Although inhibition by any alcohol did not reach a statistically significant level (Fig. 4) , the reduction in glycerol uptake by 1,3-propanediol was the greatest (about 40%), followed by 1-propanol, 1,2propanediol and 1,3-butanediol (about 30%). Substrates of several carrier-mediated transport systems known to be present in the rat small intestine were found not to inhibit glycerol uptake (Fig. 5 ). The substrates tested were D-glucose for SGLT1, 13, 14) L-ascorbate (vitamin C) for Na ϩ -dependent vitamin C transporter 1 (SVCT1), 15) L-alanine for Na ϩ -dependent amino acid transporters of System A transporter 2 (SAT2) and System ASC transporter 2 (ASCT2) and for Na ϩ -independent System L amino acid transporter 2 (LAT2), 16) and thymine and 5-fluorouracil for the Na ϩ -de- 1828 Vol. 27, No. 11 Data represent the meanϮS.E. (nϭ3). Uptake was evaluated at 37°C and 1 min (small intestine) or 5 min (colon). Sodium chloride was replaced as indicated and NaHCO 3 was replaced by KHCO 3 . a) Significantly different from the control for 2 mM at pϽ0.05. N.D., not determined. pendent pyrimidine carrier (unidentified carrier molecule). 7) Urea was also included as a test substrate to see if the carriermediated glycerol transport system might be shared by urea, as suggested for several aquaporin water channels (AQP3, 17, 18) AQP7, 19, 20) AQP9 [21] [22] [23] and AQP10 24) ). 5-Fluorouracil and adenine are also reportedly permeable through AQP9. 21) We also examined the effect of glycerol and the alcoholrelated compounds that inhibited glycerol uptake on the uptake of D-glucose (0.5 mM) and 5-fluorouracil (0.01 mM) for comparison with their effects on glycerol uptake (Table  3 ). Mephenesin was included as a reference test compound that did not alter glycerol uptake. Both D-glucose and 5-fluorouracil are known to be taken up mainly by carrier-mediated transport at the respective concentrations indicated. 7) However, none of the test compounds significantly altered the uptake of D-glucose and 5-fluorouracil.
Thus, the uptake of glycerol was selectively inhibited by glycerol-3-phosphate, chloramphenicol and voglibose, which are alcohol-related compounds analogous to glycerol. Several other compounds that did not inhibit glycerol uptake included D-glucose and 5-fluorouracil, which are known to be transported by specific carriers, and none of the selective inhibitors of glycerol uptake inhibited the uptake of D-glucose and 5-fluorouracil. Therefore, the carriers for these two compounds do not seem to be involved in glycerol uptake.
It is likely that the carrier-mediated transport system involved in glycerol uptake is specific to glycerol and, possibly, some analogous compounds that have hydroxyl groups.
Competitive Inhibition of Carrier-Mediated Glycerol Transport We selected chloramphenicol and voglibose, both of which are orally administered drugs, and further examined the mechanism by which they inhibited carrier-mediated glycerol transport. The profiles of concentration-dependent glycerol uptake in the presence of these drugs were successfully described by the model assuming competitive inhibition (Fig. 2) . The inhibition constants (K i ) of 2.77 mM for chloramphenicol and 3.39 mM for voglibose were about 4 times greater than the K m of glycerol transport (0.77 mM). Therefore, it is likely that these drugs compete with glycerol at the substrate recognition site of the carrier, although they have a lower affinity than glycerol.
DISCUSSION
Until now, the mechanism of intestinal glycerol transport has not been investigated in detail. About three decades ago, Rubin and Deren suggested that carrier-mediated transport might be involved in glycerol transport following an uptake study in vitro using tissue from the rabbit small intestine. 2) However, since then, there have been no studies addressing that issue until we recently found saturability, an indication of potential involvement of carrier-mediated transport, in glycerol absorption in the closed loop of the rat small intestine. 1) One reason for this is because glycerol is a typical small hydrophilic solute and, hence, has generally been believed to be absorbed via the paracellular route. Rubin and Deren found in their study that glycerol uptake was saturable and inhibited selectively by N-ethylmaleimide, but not by glucose, phlorizin and ethylene glycol. In the present study, we have obtained evidence that supports their earlier suggestion and have further found that carrier-mediated glycerol transport is Na ϩ -dependent and secondary active. Furthermore, it is of interest to note that the J max /K m of 14.9 ml/ min/100 mg wtw is as high as 50% of that for D-glucose transport (27 ml/min/100 mg wtw), 6) which is mediated by a highly efficient carrier, SGLT1.
Voglibose, an a-glucosidase inhibitor for the treatment of diabetes mellitus, was found to competitively inhibit the carrier-mediated transport of glycerol in the present study. It should be noted, however, that voglibose is known to be practically unabsorbable from the small intestine and acts in the small intestine to reduce the absorption of D-glucose by inhibiting the a-glucosidase-mediated hydrolytic production of D-glucose from disaccharides during the final stage of carbohydrate digestion. 25) This is an interesting example of a competitive inhibitor that cannot be transported. Assuming that a normal clinical dose of 0.2 mg would be taken with 200 ml water, the initial concentration of voglibose (molecular weight, 267.3) would be 3.7 mM. This is much lower than the K i of 3.39 mM required for its inhibition of carrier-mediated glycerol transport. Therefore, it should also be noted that voglibose would not interfere with glycerol absorption at the clinical dose.
A series of water channel proteins have recently been cloned and named aquaporins (AQPs). It is known that a group of AQPs (AQP3, AQP7, AQP9 and AQP10) act as channels also for small neutral solutes, typically glycerol and urea, and these are called aquaglyceroporins. [17] [18] [19] [20] [21] [22] [23] [24] However, permeation through channels is expected to be a linear (unsaturable) process, kinetically distinct from the saturable transport found for glycerol. Therefore, it is unlikely that these aquaglyceroporins would be involved in the carrier-mediated glycerol transport, although we cannot exclude the possibility that they might be functionally heterogeneous and act as glycerol carriers. All the aquaglyceroporins are reportedly present in the small intestine of the rat (AQP3 18) ) or the human (AQP7, 20) AQP9 23) and AQP10 24) ), although AQP7 has been detected only at a very low level. AQP3 has also been found in the rat colon. 18) However, AQP3 18) and AQP9 23) have been suggested to be localized at the basolateral membrane. Therefore, they are unlikely to be involved in carrier-mediated glycerol transport, since it is obvious that, to achieve rapid and saturable glycerol transport as observed in the present study, a carrier-mediated transport system is required at the brush border membrane for the entry of glycerol into epithelial cells. For AQP 7 and AQP10, their cellular localization has not been documented so far.
In conclusion, the present study using in vitro everted sacs of the rat small intestine strongly suggests the involvement of Na ϩ -dependent and secondary active carrier-mediated transport in the intestinal absorption of glycerol. It is likely that a carrier-mediated transport system is present in the intestine for the efficient absorption and utilization of glycerol as a nutritional substance. It could be a novel transport system specific to glycerol and some analogous compounds that have hydroxyl groups. Although the molecular entity of the carrier has not been identified, and the structural requirements of substrates remain to be fully described, it would be interesting to examine the possibility that such a carrier-mediated glycerol transport system might be involved in drug absorption and also that it might be used for oral drug delivery.
